ROYAL BANK OF CANADA - EPIRUS BIOPHARMACEUTICALS IN ownership

Back to all holdings Add to watchlist

EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 3 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of EPIRUS BIOPHARMACEUTICALS IN
ValueSharesWeighting
Q2 2016$0
-100.0%
68
-99.4%
0.00%–
Q2 2015$68,000
-53.1%
11,850
-53.7%
0.00%–
Q4 2014$145,000
-21.2%
25,5760.0%0.00%–
Q3 2014$184,000–25,576–0.00%–
 Download
Other shareholders

There were no reported owners of EPIRUS BIOPHARMACEUTICALS IN in Q3 2016.

NameSharesValueWeighting ↓
View complete list of EPIRUS BIOPHARMACEUTICALS IN shareholders